🇺🇸 FDA
Pipeline program

Echocardiographic guidance

2025-2761

Approved other active

Quick answer

Echocardiographic guidance for Aortic Stenosis is a Approved program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Aortic Stenosis
Phase
Approved
Modality
other
Status
active

Clinical trials